These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38753126)

  • 1. Health-related quality of life of adults with spinal muscular atrophy: insights from a nationwide patient registry in Germany.
    Landfeldt E; Leibrock B; Hussong J; Thiele S; Walter MC; Moehler E; Zemlin M; Dillmann U; Flotats-Bastardas M
    Qual Life Res; 2024 Jul; 33(7):1949-1959. PubMed ID: 38753126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Reported Health-Related Quality of Life of Children with Spinal Muscular Atrophy: Preliminary Insights from a Nationwide Patient Registry in Germany.
    Landfeldt E; Leibrock B; Hussong J; Thiele S; Abner S; Walter MC; Moehler E; Zemlin M; Dillmann U; Flotats-Bastardas M
    J Neuromuscul Dis; 2024; 11(1):117-128. PubMed ID: 38108360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life data for individuals affected by spinal muscular atrophy: a baseline dataset from the Cure SMA Community Update Survey.
    Belter L; Cruz R; Jarecki J
    Orphanet J Rare Dis; 2020 Aug; 15(1):217. PubMed ID: 32838797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement properties of the EQ-5D-5L and PROPr in patients with spinal muscular atrophy.
    Xu RH; Ma B; Xin H; Zhang H; Zeng Y; Luo N; Dong D
    Health Qual Life Outcomes; 2023 Nov; 21(1):123. PubMed ID: 37968716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Areas of improvement in the medical care of SMA: evidence from a nationwide patient registry in Germany.
    Leibrock B; Landfeldt E; Hussong J; Huelle T; Mattheus H; Thiele S; Walter MC; Zemlin M; Moehler E; Dillman U; Abner S; Flotats-Bastardas M
    Orphanet J Rare Dis; 2023 Feb; 18(1):32. PubMed ID: 36810103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic evaluation of Motor Neuron Diseases: a nationwide cross-sectional analysis in Germany.
    Heinrich F; Cordts I; Günther R; Stolte B; Zeller D; Schröter C; Weyen U; Regensburger M; Wolf J; Schneider I; Hermann A; Metelmann M; Kohl Z; Linker RA; Koch JC; Radelfahr F; Schönfelder E; Gardt P; Mohajer-Peseschkian T; Osmanovic A; Klopstock T; Dorst J; Ludolph AC; Schöffski O; Boentert M; Hagenacker T; Deschauer M; Lingor P; Petri S; Schreiber-Katz O
    J Neurol; 2023 Oct; 270(10):4922-4938. PubMed ID: 37356024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EQ-5D and SF-6D health utility scores in patients with spinal and bulbar muscular atrophy.
    Xu RH; Lu M; Zhang S; Dong D
    Eur J Health Econ; 2023 Nov; 24(8):1399-1410. PubMed ID: 36418784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility estimations of different health states of patients with type I, II, and III spinal muscular atrophy in China: A mixed approach study with patient and proxy-reported data.
    Hu J; Zhu L; Bao H; Liu Y; Xing H; Kang Q; Jin C
    Front Public Health; 2022; 10():1054931. PubMed ID: 36605247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease burden of spinal muscular atrophy in Germany.
    Klug C; Schreiber-Katz O; Thiele S; Schorling E; Zowe J; Reilich P; Walter MC; Nagels KH
    Orphanet J Rare Dis; 2016 May; 11(1):58. PubMed ID: 27145956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population Norms for the EQ-5D-5L, PROPr and SF-6D in Hungary.
    Nikl A; Janssen MF; Jenei B; Brodszky V; Rencz F
    Pharmacoeconomics; 2024 May; 42(5):583-603. PubMed ID: 38416366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
    Cheung PWH; Wong CKH; Cheung JPY
    Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlates of health related quality of life in adult patients with spinal muscular atrophy.
    Kruitwagen-Van Reenen ET; Wadman RI; Visser-Meily JM; van den Berg LH; Schröder C; van der Pol WL
    Muscle Nerve; 2016 Nov; 54(5):850-855. PubMed ID: 27074445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RegistrAME: the Spanish self-reported patient registry of spinal muscular atrophy.
    Cattinari MG; de Lemus M; Tizzano E
    Orphanet J Rare Dis; 2024 Feb; 19(1):76. PubMed ID: 38373977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing validity of the EQ-5D-5L proxy in children and adolescents with Duchenne muscular dystrophy or spinal muscular atrophy.
    Xu RH; Dai Y; Ng SSM; Tsang HWH; Zhang S; Dong D
    Eur J Health Econ; 2024 Feb; 25(1):103-115. PubMed ID: 36809586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life of children with spinal muscular atrophy and their caregivers from the perspective of caregivers: a Chinese cross-sectional study.
    Yao M; Ma Y; Qian R; Xia Y; Yuan C; Bai G; Mao S
    Orphanet J Rare Dis; 2021 Jan; 16(1):7. PubMed ID: 33407670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement properties of the EQ-5D-Y-3L, PedsQL 4.0, and PROMIS-25 Profile v2.0 in pediatric patients with spinal muscular atrophy.
    Xu RH; Zhao Z; Mao Z; Wang S; Xiong H; Dong D
    Health Qual Life Outcomes; 2024 Jun; 22(1):50. PubMed ID: 38937825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Social/economic costs and health-related quality of life in patients with spinal muscular atrophy (SMA) in Spain.
    López-Bastida J; Peña-Longobardo LM; Aranda-Reneo I; Tizzano E; Sefton M; Oliva-Moreno J
    Orphanet J Rare Dis; 2017 Aug; 12(1):141. PubMed ID: 28821278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of EQ-5D-5L, VAS, and SF-6D in Thai Patients on Peritoneal Dialysis.
    Thaweethamcharoen T; Noparatayaporn P; Sritippayawan S; Aiyasanon N
    Value Health Reg Issues; 2019 May; 18():59-64. PubMed ID: 30502661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating health state utilities in Duchenne muscular dystrophy using the health utilities index and EQ-5D-5L.
    Audhya IF; Szabo SM; Bever A; O'Sullivan F; Malone DC; Feeny D; Neumann P; Iannaccone ST; Jayasinghe P; Gooch KL
    J Patient Rep Outcomes; 2023 Dec; 7(1):132. PubMed ID: 38100005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service.
    Li N; Boonen A; van den Bergh JP; van Kuijk SMJ; Wyers CE; van Oostwaard M; Vranken L; Bours SPG; Hiligsmann M
    J Med Econ; 2022; 25(1):829-839. PubMed ID: 35674412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.